Also trades as: HAVN.CN (CNQ) · $vol 0M
HAVLF OTC
HAVN Life Sciences Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$8M
+24.4% ▲
Capital Expenditures
$103K
-216.1% ▼
Free Cash Flow
-$8M
+23.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
-207.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| — Operating Activities — | |||
| Net Income | -$41K | -$30M | -$22M |
| Depreciation & Amort. | $0 | $5M | $576K |
| Stock-Based Comp. | $0 | $9M | $2M |
| Change in Working Capital | -$34K | -$615K | -$536K |
| Other Non-Cash Items | -$548 | $7M | $169K |
| Operating Cash Flow | -$75K | -$10M | -$8M |
| — Investing Activities — | |||
| Capital Expenditures | $0 | -$33K | -$103K |
| Acquisitions (Net) | $0 | -$346K | -$1M |
| Investment Purchases | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 |
| Other Investing | -$250K | -$18K | -$728K |
| Investing Cash Flow | -$250K | -$397K | -$2M |
| — Financing Activities — | |||
| Net Debt Issuance | $0 | -$33K | -$131K |
| Stock Repurchased | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing | $20K | $5M | -$309K |
| Financing Cash Flow | $2M | $19M | $2M |
| Net Change in Cash | $2M | $8M | -$8M |
| Cash End of Period | $2M | $9M | $1M |
| Free Cash Flow | -$75K | -$10M | -$8M |